scholarly journals Cardiac rehabilitation and risk factor control: Always guaranteed results?

2021 ◽  
Author(s):  
Marco Ambrosetti
Keyword(s):  
Risk Factor ◽  
Cardiac Rehabilitation ◽  
Risk Factor Control

scholarly journals Digital home-based multidisciplinary cardiac rehabilitation: the way to counteract physical inactivity during the COVID-19 pandemic?

2021 ◽  
Vol 28 (Supplement_1) ◽  
Author(s):  
R Pinto ◽  
M Lemos Pires ◽  
M Borges ◽  
M Linan Pinto ◽  
C Sousa Guerreiro ◽  
...  
Keyword(s):  
Risk Factor ◽  
Exercise Training ◽  
Adverse Events ◽  
Cardiac Rehabilitation ◽  
Physical Inactivity ◽  
Dietary Habits ◽  
Training Session ◽  
Drop Out ◽  
Risk Factor Control ◽  
Home Based

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Centre-based cardiac rehabilitation (CR) programs have been forced to close due to the need for physical and social distancing imposed by COVID-19 pandemic. A major problem emerges concerning the potential harmful effects resulting from the suspension of the centre-based CR programs, leading to physical inactivity and unhealthy lifestyle routines. Therefore, the development of alternative delivery models to maintain access to CR programs and to avoid physical inactivity should be organized and tested. Purpose To assess the physical activity (PA) levels in a group of patients with known cardiovascular disease (CVD), after completing 3-months of a home-based multidisciplinary digital CR program, organized as an alternative method to the centre-based CR suspended program. Methods One hundred and sixteen patients with CVD (62.6 ± 8.9 years, 95 males) who were previously attending a face-to-face CR program were included and the following parameters were assessed at baseline and 3 months: self-reported PA and sedentary behaviour, adherence to the online CR program, cardiovascular and non-cardiovascular symptoms, feelings towards the pandemic, dietary habits, risk factor control, safety and adverse events. The intervention consisted in a multidisciplinary digital CR program, including online exercise training sessions, online educational sessions, psychological online group sessions, risk factor control, nutritional and psychological consults and patient regular assessment by cardiologist and nurse. Results Ninety-eight CVD patients successfully completed all the online assessments (15.5% drop-out). It was observed a significant increase from moderate-to-vigorous PA (230 ± 198 mins/week to 393 ± 378 mins/week, p < 0.001) and a decrease of the sedentary time at 3-months (6.47 ± 3.26 hours/day to 5.17 ± 3.18 hours/day, p < 0.001). Seventy percent of the patients met the PA recommendations and 41% reached more than 300 minutes per week of moderate to vigorous PA at 3 months. Almost half of the participants (46.9%) did at least more than one online exercise training session per week and attended at least one of the online educational sessions. There were no major adverse events reported and only one minor non-cardiovascular event occurred. Conclusion Patients with CVD, who suspended centre-based CR due to COVID-19 pandemic and started a home-based multidisciplinary digital CR program, had a significant improvement in moderate to vigorous PA after 3 months. Therefore, home-based CR programs showed to be a good option for selected clinically stable patients, who are eligible for CR and cannot attend a centre-based CR program due to COVID-19 pandemic or eventually other reasons.

scholarly journals Time trends in risk factor control and use of secondary preventive medication among patients with myocardial infarction attending cardiac rehabilitation: data from the SWEDEHEART registry 2006–2017

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
M Leosdottir ◽  
E Hagstrom ◽  
N Hadziosmanovic ◽  
A Norhammar ◽  
B Lindahl ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Risk Factor ◽  
Cardiac Rehabilitation ◽  
Central Obesity ◽  
Risk Factor Control ◽  
Time Period ◽  
Preventive Medication ◽  
Euroaspire Iii ◽  
One Year

Abstract Background Systematically monitoring results within cardiac rehabilitation (CR) has been highlighted as a possible way to improve CR outcomes. The nationwide SWEDEHEART registry has monitored quality of care post myocardial infarction (MI) in Sweden since the 1990s. Follow-up data describing treatment and outcomes within CR has been collected since 2006. Purpose To describe changes in risk factor control and use of secondary preventive medication for post MI patients after completion of CR in Sweden 2006–2017, and to compare with trends in the EUROASPIRE surveys. Methods All patients who suffered an MI and attended a one-year CR follow-up visit registered in SWEDEHEART 2006–2017 were included (n=66 666, 18–74 years, 75% men). Trends in risk factor control and secondary preventive medication were collected yearly and analyzed over the time period using Cochran-Armitage trend test. Comparisons were made to data from the EUROASPIRE III (2006–2007), IV (2012–2013) and V (2016–2017) surveys, where patients with coronary artery events or interventions were interviewed at approximately 1.2 years after the index event (n=25 225, 18–80 years, 74% men). Results Trends in blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) control, smoking, and central obesity are shown in the Figure. The proportion of patients achieving BP goal <140/90 mmHg and LDL-C goal <1.8 mmol/L increased by 16% and 29% from 2006 to 2017 in SWEDEHEART (p for trend <0.0001 for both), compared to 14% and 8% between EUROASPIRE III and V. Of patients who were active smokers at the time of the index event, the proportion still smoking at one-year remained unchanged in SWEDEHEART (43% in 2006 and 2017) while increasing from 52% to 55% in the EUROASPIRE surveys. An increase in prevalence of central obesity from approximately 50% to 60% was observed in both cohorts. The proportion of patients with obesity (BMI ≥30kg/m2) and diabetes increased in SWEDEHEART during the observed period from 23% to 29% (obesity) and 18% to 25% (diabetes) (p for trend <0.0001 for both). The proportions in 2017 were considerably lower than in EUROASPIRE V (2016–2017), where 38% were obese and 29% had diabetes. The use of statins increased from 89% to 93%, ezetimibe from 5% to 21%, and ACE/ARB from 65% to 82% in SWEDEHEART (p for trend <0.0001 for all). In comparison, in EUROASPIRE V the proportion treated with lipid lowering medication of any kind was 84% and with ACE/ARB was 75%. Conclusion Between 2006–2017, considerable improvements were achieved in risk factor control and use of secondary preventive medication for MI patients completing CR in Sweden, where all patients were monitored through the SWEDEHEART registry. The improvements were larger than observed in the EUROASPIRE surveys during the same time period. Continuous and nationwide auditing of CR outcomes, as well as local review of performance, could be possible explanations for some of the observed differences. Figure 1 Funding Acknowledgement Type of funding source: None

19-LB: Consistent Cardiovascular (CV) Benefits from Empagliflozin across the Spectrum of CV Risk Factor Control: Post Hoc Analysis from EMPA-REG OUTCOME

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 19-LB
Author(s):  
SILVIO E. INZUCCHI ◽  
KAMLESH KHUNTI ◽  
DAVID H. FITCHETT ◽  
CHRISTOPH WANNER ◽  
MICHAELA MATTHEUS ◽  
...  
Keyword(s):  
Risk Factor ◽  
Risk Factor Control ◽  
Post Hoc Analysis ◽  
Post Hoc ◽  
Control Post
Sign in / Sign up

Export Citation Format

Share Document